JPMorgan Faces Employee Lawsuit Over High Drug Costs

Court Allows Lawsuit Against JPMorgan to Proceed

A U.S. federal judge has ruled that JPMorgan Chase employees can move forward with parts of their class-action lawsuit. The suit alleges the bank mismanaged its employee health plan, resulting in excessive payments for prescription drugs and premiums.

Overview of the Allegations

The lawsuit claims JPMorgan violated the Employee Retirement Income Security Act of 1974, known as ERISA. Employees accuse the bank of allowing its pharmacy benefits manager, CVS Caremark, to implement significant markups on generic drugs, allegedly to benefit CVS, which is also an investment banking client.

According to the complaint, these markups averaged 211% across 366 generic drugs. One specific example cited is the medication teriflunomide, which was allegedly marked up by more than 38,000%, from $16.20 to $6,229.23 for a 30-unit prescription.

Potential Market and Corporate Impact

This legal challenge highlights the increasing scrutiny on corporate healthcare management and the role of pharmacy benefit managers in drug pricing. A negative outcome for JPMorgan could result in significant financial penalties and reputational damage.

The case may also set a precedent for similar lawsuits against other large corporations, potentially leading to widespread changes in how employee health benefits are administered. While Judge Jennifer Rochon dismissed claims of disloyalty, the core issue of "prohibited transactions" under ERISA will proceed.

Summary and Next Steps

JPMorgan will now have to defend against claims that it engaged in prohibited transactions with a service provider. The ruling allows the case to enter the discovery phase, though the bank may present exemptions as an affirmative defense. The financial and corporate sectors will closely monitor the developments.

FAQ

Q: What is the core accusation in the JPMorgan lawsuit?
A: Employees allege JPMorgan mismanaged its health benefits program by allowing CVS Caremark to drastically overcharge for prescription drugs, in violation of federal law.

Q: What is ERISA?
A: ERISA is the Employee Retirement Income Security Act of 1974, a federal law that sets minimum standards for most retirement and health plans in private industry to provide protection for individuals in these plans.

Q: Which part of the lawsuit was allowed to proceed?
A: The judge allowed claims related to JPMorgan allegedly engaging in "prohibited transactions" with its benefits manager, CVS Caremark, to move forward.

Source: Investing.com